# Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-iii-study-v-15-32-of-gefitinib-versus-docetaxel-in-previously-treated/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Riichiroh Maruyama,Yutaka Nishiwaki,Tomohide Tamura,Nobuyuki Yamamoto,Masahiro Tsuboi,Kazuhiko Nakagawa,Tetsu Shinkai,Shunichi Negoro,Fumio Imamura,Kenji Eguchi,Koji Takeda,Akira Inoue,Keisuke Tomii,Masao Harada,Noriyuki Masuda,Haiyi Jiang,Y. Itoh,Yukito Ichinose,Nagahiro Saijo,Masahiro Fukuoka |
| Citations | 365 |
| DOI | 10.1200/jco.2007.15.0185 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.15.0185?role=tab |
| OpenAlex ID | https://openalex.org/W2153942353 |
| PMID | 18779611 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Nobuyuki Yamamoto](https://scholariq.org/researchers/nobuyuki-yamamoto/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.